Description

ROBENAPET Tablets 6 mg

Robenacoxib for dogs and cats

Manufactured/Marketed by:

Vela Division – Panav Bio-Tech

Country of Origin: India

Dosage form: Uncoated tablets

Presentation:

30 Tablets Box

Ingredients & Composition:

Ingredient                   Amount / Strength

Robenacoxib               6 mg per uncoated tablet

Excipients                   q.s.

Description / Action:

Robenapet tablets contains robenacoxib, a selective COX-2 NSAID for pain and inflammation management in dogs and cats.

The 1st USFDA-approved veterinary NSAID-selective COX-2 inhibition for powerful analgesia with minimal gastric irritation and improved renal safety profile.

Key highlights from the brochure:

1st USFDA Approved Vet NSAID: Robenacoxib is the first NSAID specifically designed and approved for veterinary medicine.

Selective COX-2 Inhibition: Targeted prostaglandin reduction with minimal COX-1 inhibition — gastroprotective.

Rapid Analgesic Onset: Fast-acting pain and inflammation control.

Improved Renal Safety: More renal-sparing than non-selective NSAIDs — suitable for high-risk patients.

High Patient Compliance: Palatable uncoated tablets — accepted willingly by most dogs and cats.

Tissue-Targeted Distribution: Accumulates at inflamed tissues, with lower plasma exposure and faster onset of action.

Mechanism of Action: Inhibits COX-2 enzyme, suppresses inflammatory mediators, reduces peripheral sensitization and improves mobility.

Robenacoxib is a coxib-class NSAID with preferential/selective inhibition of COX-2 and has analgesic, anti-inflammatory and antipyretic effects.

Class:

Non-Steroidal Anti-Inflammatory Drug (NSAID) — Coxib / selective COX-2 inhibitor

Indication / Uses:

Post-Surgical Pain: Management of acute pain following orthopaedic and soft-tissue surgery

Osteoarthritis: Long-term management of chronic joint pain and inflammation

Trauma & Lameness: Acute musculoskeletal pain from trauma, sprains and strains

Dental Procedures: Post-operative pain control following dental extractions and oral surgery

GI-Sensitive Cases: Preferred in dogs with prior GI sensitivity to non-selective NSAIDs

Dosage and Administration:

Overdoses / Side Effects / Contraindications / Warnings:

Like other NSAIDs, adverse effects may include vomiting, diarrhoea and decreased appetite. Use cautiously in animals with renal, hepatic or gastrointestinal disease, dehydration, or conditions that may compromise renal perfusion.

Do not combine with another NSAID or corticosteroid unless specifically directed by a veterinarian.

Concurrent use with potentially nephrotoxic medicines requires caution.

Accidental overdose requires veterinary assessment.

Pharmaceutical Precautions / Instructions:

Use only under veterinary direction.

Determine dose according to accurate body weight.

Monitor patients receiving NSAIDs, particularly those with pre-existing renal, hepatic or gastrointestinal disease.

Avoid concurrent administration of other NSAIDs or corticosteroids.

Perioperative patients should be appropriately hydrated because anaesthesia can affect renal perfusion.

Safety: Age / Pregnancy / Withdrawal:

Age: No minimum age is specified by the manufacturer.

Pregnancy/Lactation:
No product-specific pregnancy or lactation statement is provided. Use should be based on veterinary risk-benefit assessment.

Withdrawal:
Not stated. This product is presented for dogs and cats rather than food-producing animals.

Substitute: Robenatail Tablets